O. Muto

HGCSG1901: A retrospective cohort study evaluating the safety and efficacy of S-1 and irinotecan plus bevacizumab in patients with metastatic colorectal cancer: Analysis of second-line treatment after anti-EGFR antibody

Background Although the selection of anti-EGFR antibody as first-line treatment for metastatic colorectal cancer (mCRC) patients is now decided based on primary tumor lo...

H. Okuda ;

Y. Sasaki ;

Yasuhiro Sakata ;

M. Nakamura ;

S. Yuki ;

Taisei J. Kobayashi , MD;

Y. Komatsu ;

M. Dazai ;

T. Sasaki ;

H. Nakatsumi ;

A. Sato ;

A. Ueda ;

Ayako Yoshikawa , MD;

K. Ito ;

Y. Kawamoto ;

R. Saito ;

T. Yamamura ;

M. Yagisawa ;

A. Ishiguro ;

O. Muto ;

K. Hatanaka ;

06/28/2021

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

O. Muto

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products